184 related articles for article (PubMed ID: 38539479)
41. Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy.
Dora D; Bokhari SMZ; Aloss K; Takacs P; Desnoix JZ; Szklenárik G; Hurley PD; Lohinai Z
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769093
[TBL] [Abstract][Full Text] [Related]
42. Curcumin protects mice with myasthenia gravis by regulating the gut microbiota, short-chain fatty acids, and the Th17/Treg balance.
Sun J; Xie Q; Sun M; Zhang W; Wang H; Liu N; Wang M
Heliyon; 2024 Feb; 10(4):e26030. PubMed ID: 38420408
[TBL] [Abstract][Full Text] [Related]
43. Biomarkers for assessment of intestinal permeability in clinical practice.
Seethaler B; Basrai M; Neyrinck AM; Nazare JA; Walter J; Delzenne NM; Bischoff SC
Am J Physiol Gastrointest Liver Physiol; 2021 Jul; 321(1):G11-G17. PubMed ID: 34009040
[TBL] [Abstract][Full Text] [Related]
44. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
45. Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.
Vernocchi P; Gili T; Conte F; Del Chierico F; Conta G; Miccheli A; Botticelli A; Paci P; Caldarelli G; Nuti M; Marchetti P; Putignani L
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227982
[TBL] [Abstract][Full Text] [Related]
46. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial.
Seethaler B; Nguyen NK; Basrai M; Kiechle M; Walter J; Delzenne NM; Bischoff SC
Am J Clin Nutr; 2022 Oct; 116(4):928-942. PubMed ID: 36055959
[TBL] [Abstract][Full Text] [Related]
47. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
48. Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension.
Overby HB; Ferguson JF
Curr Hypertens Rep; 2021 Feb; 23(2):8. PubMed ID: 33537923
[TBL] [Abstract][Full Text] [Related]
49. Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet.
Calabrese CM; Valentini A; Calabrese G
Front Nutr; 2020; 7():612773. PubMed ID: 33521039
[TBL] [Abstract][Full Text] [Related]
50. Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids.
Ma H; Yu Y; Wang M; Li Z; Xu H; Tian C; Zhang J; Ye X; Li X
Apoptosis; 2019 Feb; 24(1-2):168-183. PubMed ID: 30506375
[TBL] [Abstract][Full Text] [Related]
51. Role of gut microbiome in the outcome of cancer immunotherapy.
Ma J; Zhu W; Liu B
Int J Cancer; 2021 Feb; ():. PubMed ID: 33600603
[TBL] [Abstract][Full Text] [Related]
52. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
Gomes S; Rodrigues AC; Pazienza V; Preto A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
[TBL] [Abstract][Full Text] [Related]
53. Effect of dark sweet cherry powder consumption on the gut microbiota, short-chain fatty acids, and biomarkers of gut health in obese db/db mice.
Garcia-Mazcorro JF; Lage NN; Mertens-Talcott S; Talcott S; Chew B; Dowd SE; Kawas JR; Noratto GD
PeerJ; 2018; 6():e4195. PubMed ID: 29312822
[TBL] [Abstract][Full Text] [Related]
54. Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function.
Zhang YW; Cao MM; Li YJ; Lu PP; Dai GC; Zhang M; Wang H; Rui YF
J Orthop Translat; 2022 Nov; 37():46-60. PubMed ID: 36196151
[TBL] [Abstract][Full Text] [Related]
55. Eosinophil and IFN-γ associated with immune-related adverse events as prognostic markers in patients with non-small cell lung cancer treated with immunotherapy.
Hu WT; Zhang Q; Zhang Z; He X; Zhou M; Guo Y; Wang X
Front Immunol; 2023; 14():1112409. PubMed ID: 36949952
[TBL] [Abstract][Full Text] [Related]
56. Gut Microbiological Disorders Reduce Semen Utilization Rate in Duroc Boars.
Guo L; Wu Y; Wang C; Wei H; Tan J; Sun H; Jiang S; Peng J
Front Microbiol; 2020; 11():581926. PubMed ID: 33133051
[TBL] [Abstract][Full Text] [Related]
57. Gut microbiota shed new light on the management of immune-related adverse events.
Tan B; Liu YX; Tang H; Chen D; Xu Y; Chen MJ; Li Y; Wang MZ; Qian JM
Thorac Cancer; 2022 Oct; 13(19):2681-2691. PubMed ID: 36043345
[TBL] [Abstract][Full Text] [Related]
58. Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.
Pavan A; Calvetti L; Dal Maso A; Attili I; Del Bianco P; Pasello G; Guarneri V; Aprile G; Conte P; Bonanno L
Oncologist; 2019 Aug; 24(8):1128-1136. PubMed ID: 31015312
[TBL] [Abstract][Full Text] [Related]
59. Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer.
Akamatsu H; Murakami E; Oyanagi J; Shibaki R; Kaki T; Takase E; Tanaka M; Harutani Y; Yamagata N; Okuda Y; Furuta K; Sugimoto T; Teraoka S; Hayata A; Tokudome N; Ozawa Y; Mori K; Koh Y; Yamamoto N
Oncologist; 2020 Apr; 25(4):e679-e683. PubMed ID: 32297443
[TBL] [Abstract][Full Text] [Related]
60. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
